{"gene":"EPOP","run_date":"2026-06-09T23:54:43","timeline":{"discoveries":[{"year":2014,"finding":"C17orf96 (EPOP) physically interacts with EZH2/PRC2 as a strong interactor, at levels similar to canonical PRC2 components (SUZ12, EED, MTF2, JARID2, PHF1, AEBP2), and co-localizes genome-wide with EZH2 and H3K27me3. Mass spectrometry revealed that C17orf96 and C10orf12 are mutually exclusive PRC2 subunits that do not interact with each other or with JARID2 and AEBP2.","method":"BioTAP-XL cross-linking affinity purification, mass spectrometry, ChIP-seq","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — cross-linking affinity purification combined with ChIP-seq and MS validation; replicated by subsequent independent studies","pmids":["24550272"],"is_preprint":false},{"year":2015,"finding":"C17orf96 (EPOP) is present at most CpG islands (CGIs) in mouse ES cells. At PRC2-rich CGIs, loss of C17orf96 increases Suz12 chromatin binding and H3K27me3 levels concomitant with gene repression, indicating EPOP antagonizes PRC2 activity there. At PRC2-poor, actively transcribed CGIs, C17orf96 colocalizes with RNA Pol II and its depletion causes a focusing of H3K4me3 at the CGI core, indicating a role in modulating active transcription.","method":"ChIP-seq, knockdown/depletion, genome-wide analysis","journal":"Cell discovery","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genome-wide ChIP-seq with depletion, single lab, two orthogonal chromatin readouts","pmids":["27462409"],"is_preprint":false},{"year":2016,"finding":"EPOP recruits Elongin BC to the promoters of PRC2 bivalent target genes in pluripotent stem cells. Biochemical analyses show EPOP physically bridges Elongin BC and PRC2. Both EPOP and Elongin BC are required to maintain low levels of expression at PRC2 genomic targets, indicating EPOP functionally links transcription elongation activity to Polycomb repression.","method":"Co-immunoprecipitation, genome-wide ChIP-seq, knockdown with gene expression analysis","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP, genome-wide chromatin profiling, and functional depletion experiments; replicated independently in two concurrent papers","pmids":["27863225"],"is_preprint":false},{"year":2016,"finding":"EPOP interacts with the transcription elongation factor Elongin BC and the H2B deubiquitinase USP7 in mouse ESCs. EPOP co-localizes at chromatin with members of both the Myc and Polycomb transcriptional modules. Loss of EPOP impairs proliferation of human cancer cell lines, and its depletion modulates transcriptional processes similar to MYC.","method":"Co-immunoprecipitation, genome-wide ChIP-seq, knockdown/loss-of-function proliferation assays","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP for multiple binding partners, genome-wide chromatin profiling, functional KD phenotype; independently published alongside Beringer et al. 2016","pmids":["27863226"],"is_preprint":false},{"year":2024,"finding":"EPOP directly modulates the oligomerization state of PRC2.1 by disrupting PRC2.1 dimerization, thereby weakening its chromatin association (likely by disabling avidity conferred by the dimeric complex). An EPOP mutant specifically defective in PRC2 binding enhances genome-wide enrichments of MTF2 and H3K27me3, confirming the inhibitory function is PRC2-dependent. Elongin BC is largely dispensable for this EPOP-mediated inhibition of PRC2.1.","method":"Biochemical dimerization assays, EPOP PRC2-binding mutant analysis, genome-wide ChIP-seq in mouse epiblast-like cells","journal":"bioRxiv : the preprint server for biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — biochemical oligomerization assays plus genome-wide functional validation with separation-of-function mutant; preprint, single lab","pmids":["39314288"],"is_preprint":true},{"year":2026,"finding":"EPOP restricts PRC2.1 chromatin targeting by directly disrupting PRC2.1 dimerization and weakening its chromatin association via loss of avidity. An EPOP PRC2-binding-deficient mutant enhances MTF2 genome-wide enrichment. Elongin BC is largely dispensable for EPOP-mediated PRC2.1 inhibition. EPOP defines a distinct PRC2.1 subclass that prevents over-repression of key gene regulators during early differentiation.","method":"Biochemical dimerization assays, separation-of-function EPOP mutant, genome-wide ChIP-seq in mouse epiblast-like cells","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — peer-reviewed publication of the preprint with biochemical reconstitution of dimerization effect, separation-of-function mutant, and genome-wide validation; single lab but multiple orthogonal methods","pmids":["41519789"],"is_preprint":false},{"year":2025,"finding":"EPOP stimulates PRC2 histone methyltransferase (HMT) activity in vitro. Using reconstituted dinucleosome substrates, EPOP promotes PRC2 chromatin-binding activity in a DNA-sequence-dependent manner (preferring GCN-rich sequences). EPOP is ineffectual in PRC2 chromatin recruitment alone (EED-rescue system in vivo) but promotes H3K27me3 deposition de novo in cooperation with MTF2 and JARID2.","method":"In vitro HMT assay, reconstituted dinucleosome binding assays, EED-rescue in vivo system, genome-wide analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro enzymatic reconstitution with biochemical binding assays on defined substrates plus in vivo validation; single lab, multiple orthogonal methods","pmids":["41650228"],"is_preprint":false},{"year":2025,"finding":"The crystal structure of the EPOP BC-box peptide bound to the Elongin BC complex reveals that the conserved leucine residue (Leu40) within EPOP's BC-box is deeply embedded in the hydrophobic pocket of Elongin C, defining the molecular basis for EPOP–Elongin BC interaction. The binding mode is structurally conserved with other BC-box-containing proteins.","method":"X-ray crystallography","journal":"Biochemical and biophysical research communications","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structure of peptide–protein complex with atomic-level detail of key interface residue; single lab but Tier 1 method","pmids":["40153999"],"is_preprint":false},{"year":2025,"finding":"Epop knockout mice are viable and fertile but display highly penetrant posterior homeotic transformations of the axial skeleton. Epop-depleted embryos show a shifted anterior expression boundary of certain Hox genes, originating at the level of the presomitic mesoderm. EPOP prevents premature activation of a subset of Hox genes required for correct antero-posterior body patterning.","method":"Mouse knockout model, tissue-specific RNA-seq, skeletal phenotyping, Hox gene expression analysis","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — clean mouse KO with defined skeletal phenotype, tissue-specific RNA-seq tracing mechanism to presomitic mesoderm, and specific Hox gene expression readout; single lab, multiple orthogonal methods","pmids":["40834979"],"is_preprint":false}],"current_model":"EPOP (C17orf96) is an accessory subunit specific to PRC2.1 complexes that plays a dual and context-dependent role: it physically bridges PRC2 with Elongin BC (via a conserved BC-box, with Leu40 embedded in the Elongin C hydrophobic pocket) and with USP7, recruits these factors to bivalent and actively transcribed CpG island promoters in pluripotent stem cells, and stimulates PRC2 histone methyltransferase activity in vitro in a GCN-rich DNA-sequence-dependent manner in cooperation with MTF2 and JARID2; simultaneously, EPOP inhibits PRC2.1 chromatin over-targeting by disrupting PRC2.1 dimerization and reducing avidity-driven chromatin association (independently of Elongin BC), thereby maintaining low but non-zero expression at Polycomb target genes—a function essential in vivo for preventing premature Hox gene activation and ensuring correct axial skeletal patterning."},"narrative":{"mechanistic_narrative":"EPOP (C17orf96) is an accessory, PRC2-specific subunit that fine-tunes Polycomb repressive complex 2 activity at CpG island promoters, balancing repression against active transcription rather than acting as a simple silencer [PMID:24550272, PMID:27462409]. It is a strong, mutually exclusive PRC2 subunit (exclusive of C10orf12) that co-localizes genome-wide with EZH2 and H3K27me3 [PMID:24550272]. Mechanistically, EPOP physically bridges PRC2 to the transcription elongation factor Elongin BC and to the deubiquitinase USP7, recruiting these factors to bivalent and actively transcribed targets to keep target genes expressed at low but non-zero levels [PMID:27863225, PMID:27863226]; the EPOP–Elongin BC interface is defined structurally, with the conserved BC-box leucine (Leu40) embedded in the hydrophobic pocket of Elongin C [PMID:40153999]. EPOP exerts opposing activities on PRC2: in vitro it stimulates PRC2 histone methyltransferase activity and promotes chromatin binding in a GCN-rich, DNA-sequence-dependent manner, depositing H3K27me3 de novo in cooperation with MTF2 and JARID2 [PMID:41650228], while in cells it restrains PRC2.1 by disrupting complex dimerization and reducing avidity-driven chromatin association, an inhibitory function that is PRC2-dependent but largely independent of Elongin BC [PMID:39314288, PMID:41519789]. This restraint of PRC2.1 over-targeting is required in vivo: Epop-knockout mice are viable but show highly penetrant posterior homeotic transformations arising from premature, anteriorly shifted Hox gene activation in the presomitic mesoderm [PMID:40834979].","teleology":[{"year":2014,"claim":"Establishing that C17orf96/EPOP is a bona fide PRC2 subunit answered whether this uncharacterized protein belongs to the Polycomb machinery and defined its mutual exclusivity with C10orf12.","evidence":"BioTAP-XL cross-linking affinity purification with mass spectrometry and ChIP-seq in cells","pmids":["24550272"],"confidence":"High","gaps":["Did not resolve whether EPOP activates or restrains PRC2","No structural or domain-level interaction map","Functional consequence of incorporation untested"]},{"year":2015,"claim":"Genome-wide depletion revealed that EPOP has opposite effects at PRC2-rich versus active CpG islands, establishing it as a context-dependent modulator rather than a uniform repressor or activator.","evidence":"ChIP-seq with depletion in mouse ES cells reading H3K27me3, Suz12, Pol II and H3K4me3","pmids":["27462409"],"confidence":"Medium","gaps":["Molecular basis of the antagonism at PRC2-rich sites unresolved","Direct partners mediating active-transcription role not yet identified","Single lab"]},{"year":2016,"claim":"Identifying Elongin BC and USP7 as EPOP partners showed how EPOP physically couples PRC2 to transcription elongation and deubiquitination machinery to maintain low expression at target genes.","evidence":"Reciprocal co-immunoprecipitation, genome-wide ChIP-seq, and knockdown expression/proliferation assays in mouse ESCs and human cancer lines (two concurrent papers)","pmids":["27863225","27863226"],"confidence":"High","gaps":["Atomic basis of the EPOP–Elongin BC interface not defined","Functional role of USP7 recruitment not mechanistically dissected","Link to Myc module correlative"]},{"year":2025,"claim":"Crystallography of the EPOP BC-box bound to Elongin BC pinpointed Leu40 in the Elongin C hydrophobic pocket, giving the structural basis for the bridging interaction.","evidence":"X-ray crystallography of the EPOP BC-box peptide–Elongin BC complex","pmids":["40153999"],"confidence":"High","gaps":["Structure of full-length EPOP within PRC2 not determined","Does not address the Elongin-BC-independent inhibitory function"]},{"year":2025,"claim":"Reconstituted enzymatic assays demonstrated that EPOP stimulates PRC2 methyltransferase activity in a GCN-rich DNA-sequence-dependent manner, defining a positive, cooperative role with MTF2 and JARID2.","evidence":"In vitro HMT and dinucleosome binding assays on defined substrates plus EED-rescue in vivo system","pmids":["41650228"],"confidence":"High","gaps":["How sequence preference is read out mechanistically unclear","Reconciliation with in-cell inhibitory role not fully resolved","Single lab"]},{"year":2026,"claim":"Separation-of-function mutants and dimerization assays established that EPOP restrains PRC2.1 by disrupting dimerization and lowering chromatin avidity, defining a distinct PRC2.1 subclass that prevents over-repression.","evidence":"Biochemical dimerization assays, PRC2-binding-deficient EPOP mutant, and genome-wide ChIP-seq in mouse epiblast-like cells (peer-reviewed publication of the 2024 preprint)","pmids":["41519789","39314288"],"confidence":"High","gaps":["Structural detail of the dimerization-disrupting interaction not resolved","How activating and inhibitory modes are partitioned across loci unknown"]},{"year":2025,"claim":"An Epop-knockout mouse linked EPOP's molecular restraint of PRC2 to organismal axial patterning, showing it prevents premature Hox activation in the presomitic mesoderm.","evidence":"Mouse knockout with skeletal phenotyping, tissue-specific RNA-seq, and Hox expression boundary analysis","pmids":["40834979"],"confidence":"High","gaps":["Which EPOP biochemical activity (dimerization restraint vs Elongin BC bridging) drives the phenotype not dissected","Human disease relevance untested"]},{"year":null,"claim":"How EPOP's opposing activities — stimulating PRC2 methyltransferase activity yet restraining PRC2.1 chromatin over-targeting — are mechanistically partitioned at individual loci and contexts remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model integrating activation and inhibition at the same target","Role of USP7/H2B deubiquitination in the switch undefined","No structure of EPOP within an intact PRC2.1 dimer"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[2,3]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[4,5,6]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[6]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,1]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[0,1,2]}],"pathway":[{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[0,1,6]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[2,3]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[8]}],"complexes":["PRC2.1"],"partners":["EZH2","SUZ12","MTF2","JARID2","USP7","ELOB","ELOC"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"A6NHQ4","full_name":"Elongin BC and Polycomb repressive complex 2-associated protein","aliases":["Proline-rich protein 28"],"length_aa":379,"mass_kda":39.3,"function":"Scaffold protein that serves as a bridging partner between the PRC2/EZH2 complex and the elongin BC complex: required to fine-tune the transcriptional status of Polycomb group (PcG) target genes in embryonic stem cells (ESCs). Plays a key role in genomic regions that display both active and repressive chromatin properties in pluripotent stem cells by sustaining low level expression at PcG target genes: acts by recruiting the elongin BC complex, thereby restricting excessive activity of the PRC2/EZH2 complex. Interaction with USP7 promotes deubiquitination of H2B at promoter sites. Acts as a regulator of neuronal differentiation","subcellular_location":"Nucleus; Chromosome","url":"https://www.uniprot.org/uniprotkb/A6NHQ4/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/EPOP","classification":"Common Essential","n_dependent_lines":778,"n_total_lines":1208,"dependency_fraction":0.6440397350993378},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/EPOP","total_profiled":1310},"omim":[{"mim_id":"617795","title":"ELONGIN BC- AND POLYCOMB REPRESSIVE COMPLEX 2-ASSOCIATED PROTEIN; EPOP","url":"https://www.omim.org/entry/617795"},{"mim_id":"607698","title":"LIGAND-DEPENDENT NUCLEAR RECEPTOR COREPRESSOR; LCOR","url":"https://www.omim.org/entry/607698"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Cytosol","reliability":"Additional"},{"location":"Cytoplasmic bodies","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":13.5},{"tissue":"testis","ntpm":11.1}],"url":"https://www.proteinatlas.org/search/EPOP"},"hgnc":{"alias_symbol":["LOC100170841","PRR28"],"prev_symbol":["C17orf96"]},"alphafold":{"accession":"A6NHQ4","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/A6NHQ4","model_url":"https://alphafold.ebi.ac.uk/files/AF-A6NHQ4-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-A6NHQ4-F1-predicted_aligned_error_v6.png","plddt_mean":58.53},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=EPOP","jax_strain_url":"https://www.jax.org/strain/search?query=EPOP"},"sequence":{"accession":"A6NHQ4","fasta_url":"https://rest.uniprot.org/uniprotkb/A6NHQ4.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/A6NHQ4/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/A6NHQ4"}},"corpus_meta":[{"pmid":"27863225","id":"PMC_27863225","title":"EPOP Functionally Links Elongin and Polycomb in Pluripotent Stem Cells.","date":"2016","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/27863225","citation_count":122,"is_preprint":false},{"pmid":"27863226","id":"PMC_27863226","title":"EPOP Interacts with Elongin BC and USP7 to Modulate the Chromatin Landscape.","date":"2016","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/27863226","citation_count":95,"is_preprint":false},{"pmid":"24550272","id":"PMC_24550272","title":"Reciprocal interactions of human C10orf12 and C17orf96 with PRC2 revealed by BioTAP-XL cross-linking and affinity purification.","date":"2014","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/24550272","citation_count":80,"is_preprint":false},{"pmid":"27462409","id":"PMC_27462409","title":"The PRC2-associated factor C17orf96 is a novel CpG island regulator in mouse ES cells.","date":"2015","source":"Cell discovery","url":"https://pubmed.ncbi.nlm.nih.gov/27462409","citation_count":30,"is_preprint":false},{"pmid":"27863221","id":"PMC_27863221","title":"The Dual Role of EPOP and Elongin BC in Controlling Transcriptional Activity.","date":"2016","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/27863221","citation_count":3,"is_preprint":false},{"pmid":"41519789","id":"PMC_41519789","title":"EPOP restricts PRC2.1 targeting to chromatin by directly modulating enzyme complex dimerization.","date":"2026","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/41519789","citation_count":2,"is_preprint":false},{"pmid":"39314288","id":"PMC_39314288","title":"EPOP Restricts PRC2.1 Targeting to Chromatin by Directly Modulating Enzyme Complex Dimerization.","date":"2024","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/39314288","citation_count":2,"is_preprint":false},{"pmid":"41040190","id":"PMC_41040190","title":"EPOP and MTF2 Activate PRC2 Activity through DNA-sequence specificity.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/41040190","citation_count":1,"is_preprint":false},{"pmid":"41650228","id":"PMC_41650228","title":"EPOP and MTF2 activate PRC2 activity through DNA-sequence specificity.","date":"2026","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/41650228","citation_count":1,"is_preprint":false},{"pmid":"40153999","id":"PMC_40153999","title":"Structural analysis of EPOP BC-box binding to the elongin BC complex.","date":"2025","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/40153999","citation_count":1,"is_preprint":false},{"pmid":"40834979","id":"PMC_40834979","title":"The PRC2-associated factor EPOP is required for Hox gene regulation during axial development in mice.","date":"2025","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/40834979","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":6544,"output_tokens":2598,"usd":0.029301,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9799,"output_tokens":2927,"usd":0.061085,"stage2_stop_reason":"end_turn"},"total_usd":0.090386,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2014,\n      \"finding\": \"C17orf96 (EPOP) physically interacts with EZH2/PRC2 as a strong interactor, at levels similar to canonical PRC2 components (SUZ12, EED, MTF2, JARID2, PHF1, AEBP2), and co-localizes genome-wide with EZH2 and H3K27me3. Mass spectrometry revealed that C17orf96 and C10orf12 are mutually exclusive PRC2 subunits that do not interact with each other or with JARID2 and AEBP2.\",\n      \"method\": \"BioTAP-XL cross-linking affinity purification, mass spectrometry, ChIP-seq\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cross-linking affinity purification combined with ChIP-seq and MS validation; replicated by subsequent independent studies\",\n      \"pmids\": [\"24550272\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"C17orf96 (EPOP) is present at most CpG islands (CGIs) in mouse ES cells. At PRC2-rich CGIs, loss of C17orf96 increases Suz12 chromatin binding and H3K27me3 levels concomitant with gene repression, indicating EPOP antagonizes PRC2 activity there. At PRC2-poor, actively transcribed CGIs, C17orf96 colocalizes with RNA Pol II and its depletion causes a focusing of H3K4me3 at the CGI core, indicating a role in modulating active transcription.\",\n      \"method\": \"ChIP-seq, knockdown/depletion, genome-wide analysis\",\n      \"journal\": \"Cell discovery\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genome-wide ChIP-seq with depletion, single lab, two orthogonal chromatin readouts\",\n      \"pmids\": [\"27462409\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"EPOP recruits Elongin BC to the promoters of PRC2 bivalent target genes in pluripotent stem cells. Biochemical analyses show EPOP physically bridges Elongin BC and PRC2. Both EPOP and Elongin BC are required to maintain low levels of expression at PRC2 genomic targets, indicating EPOP functionally links transcription elongation activity to Polycomb repression.\",\n      \"method\": \"Co-immunoprecipitation, genome-wide ChIP-seq, knockdown with gene expression analysis\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP, genome-wide chromatin profiling, and functional depletion experiments; replicated independently in two concurrent papers\",\n      \"pmids\": [\"27863225\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"EPOP interacts with the transcription elongation factor Elongin BC and the H2B deubiquitinase USP7 in mouse ESCs. EPOP co-localizes at chromatin with members of both the Myc and Polycomb transcriptional modules. Loss of EPOP impairs proliferation of human cancer cell lines, and its depletion modulates transcriptional processes similar to MYC.\",\n      \"method\": \"Co-immunoprecipitation, genome-wide ChIP-seq, knockdown/loss-of-function proliferation assays\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP for multiple binding partners, genome-wide chromatin profiling, functional KD phenotype; independently published alongside Beringer et al. 2016\",\n      \"pmids\": [\"27863226\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"EPOP directly modulates the oligomerization state of PRC2.1 by disrupting PRC2.1 dimerization, thereby weakening its chromatin association (likely by disabling avidity conferred by the dimeric complex). An EPOP mutant specifically defective in PRC2 binding enhances genome-wide enrichments of MTF2 and H3K27me3, confirming the inhibitory function is PRC2-dependent. Elongin BC is largely dispensable for this EPOP-mediated inhibition of PRC2.1.\",\n      \"method\": \"Biochemical dimerization assays, EPOP PRC2-binding mutant analysis, genome-wide ChIP-seq in mouse epiblast-like cells\",\n      \"journal\": \"bioRxiv : the preprint server for biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — biochemical oligomerization assays plus genome-wide functional validation with separation-of-function mutant; preprint, single lab\",\n      \"pmids\": [\"39314288\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"EPOP restricts PRC2.1 chromatin targeting by directly disrupting PRC2.1 dimerization and weakening its chromatin association via loss of avidity. An EPOP PRC2-binding-deficient mutant enhances MTF2 genome-wide enrichment. Elongin BC is largely dispensable for EPOP-mediated PRC2.1 inhibition. EPOP defines a distinct PRC2.1 subclass that prevents over-repression of key gene regulators during early differentiation.\",\n      \"method\": \"Biochemical dimerization assays, separation-of-function EPOP mutant, genome-wide ChIP-seq in mouse epiblast-like cells\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — peer-reviewed publication of the preprint with biochemical reconstitution of dimerization effect, separation-of-function mutant, and genome-wide validation; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"41519789\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"EPOP stimulates PRC2 histone methyltransferase (HMT) activity in vitro. Using reconstituted dinucleosome substrates, EPOP promotes PRC2 chromatin-binding activity in a DNA-sequence-dependent manner (preferring GCN-rich sequences). EPOP is ineffectual in PRC2 chromatin recruitment alone (EED-rescue system in vivo) but promotes H3K27me3 deposition de novo in cooperation with MTF2 and JARID2.\",\n      \"method\": \"In vitro HMT assay, reconstituted dinucleosome binding assays, EED-rescue in vivo system, genome-wide analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro enzymatic reconstitution with biochemical binding assays on defined substrates plus in vivo validation; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"41650228\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"The crystal structure of the EPOP BC-box peptide bound to the Elongin BC complex reveals that the conserved leucine residue (Leu40) within EPOP's BC-box is deeply embedded in the hydrophobic pocket of Elongin C, defining the molecular basis for EPOP–Elongin BC interaction. The binding mode is structurally conserved with other BC-box-containing proteins.\",\n      \"method\": \"X-ray crystallography\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structure of peptide–protein complex with atomic-level detail of key interface residue; single lab but Tier 1 method\",\n      \"pmids\": [\"40153999\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Epop knockout mice are viable and fertile but display highly penetrant posterior homeotic transformations of the axial skeleton. Epop-depleted embryos show a shifted anterior expression boundary of certain Hox genes, originating at the level of the presomitic mesoderm. EPOP prevents premature activation of a subset of Hox genes required for correct antero-posterior body patterning.\",\n      \"method\": \"Mouse knockout model, tissue-specific RNA-seq, skeletal phenotyping, Hox gene expression analysis\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean mouse KO with defined skeletal phenotype, tissue-specific RNA-seq tracing mechanism to presomitic mesoderm, and specific Hox gene expression readout; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"40834979\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"EPOP (C17orf96) is an accessory subunit specific to PRC2.1 complexes that plays a dual and context-dependent role: it physically bridges PRC2 with Elongin BC (via a conserved BC-box, with Leu40 embedded in the Elongin C hydrophobic pocket) and with USP7, recruits these factors to bivalent and actively transcribed CpG island promoters in pluripotent stem cells, and stimulates PRC2 histone methyltransferase activity in vitro in a GCN-rich DNA-sequence-dependent manner in cooperation with MTF2 and JARID2; simultaneously, EPOP inhibits PRC2.1 chromatin over-targeting by disrupting PRC2.1 dimerization and reducing avidity-driven chromatin association (independently of Elongin BC), thereby maintaining low but non-zero expression at Polycomb target genes—a function essential in vivo for preventing premature Hox gene activation and ensuring correct axial skeletal patterning.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"EPOP (C17orf96) is an accessory, PRC2-specific subunit that fine-tunes Polycomb repressive complex 2 activity at CpG island promoters, balancing repression against active transcription rather than acting as a simple silencer [#0, #1]. It is a strong, mutually exclusive PRC2 subunit (exclusive of C10orf12) that co-localizes genome-wide with EZH2 and H3K27me3 [#0]. Mechanistically, EPOP physically bridges PRC2 to the transcription elongation factor Elongin BC and to the deubiquitinase USP7, recruiting these factors to bivalent and actively transcribed targets to keep target genes expressed at low but non-zero levels [#2, #3]; the EPOP–Elongin BC interface is defined structurally, with the conserved BC-box leucine (Leu40) embedded in the hydrophobic pocket of Elongin C [#7]. EPOP exerts opposing activities on PRC2: in vitro it stimulates PRC2 histone methyltransferase activity and promotes chromatin binding in a GCN-rich, DNA-sequence-dependent manner, depositing H3K27me3 de novo in cooperation with MTF2 and JARID2 [#6], while in cells it restrains PRC2.1 by disrupting complex dimerization and reducing avidity-driven chromatin association, an inhibitory function that is PRC2-dependent but largely independent of Elongin BC [#4, #5]. This restraint of PRC2.1 over-targeting is required in vivo: Epop-knockout mice are viable but show highly penetrant posterior homeotic transformations arising from premature, anteriorly shifted Hox gene activation in the presomitic mesoderm [#8].\",\n  \"teleology\": [\n    {\n      \"year\": 2014,\n      \"claim\": \"Establishing that C17orf96/EPOP is a bona fide PRC2 subunit answered whether this uncharacterized protein belongs to the Polycomb machinery and defined its mutual exclusivity with C10orf12.\",\n      \"evidence\": \"BioTAP-XL cross-linking affinity purification with mass spectrometry and ChIP-seq in cells\",\n      \"pmids\": [\"24550272\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve whether EPOP activates or restrains PRC2\", \"No structural or domain-level interaction map\", \"Functional consequence of incorporation untested\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Genome-wide depletion revealed that EPOP has opposite effects at PRC2-rich versus active CpG islands, establishing it as a context-dependent modulator rather than a uniform repressor or activator.\",\n      \"evidence\": \"ChIP-seq with depletion in mouse ES cells reading H3K27me3, Suz12, Pol II and H3K4me3\",\n      \"pmids\": [\"27462409\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular basis of the antagonism at PRC2-rich sites unresolved\", \"Direct partners mediating active-transcription role not yet identified\", \"Single lab\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Identifying Elongin BC and USP7 as EPOP partners showed how EPOP physically couples PRC2 to transcription elongation and deubiquitination machinery to maintain low expression at target genes.\",\n      \"evidence\": \"Reciprocal co-immunoprecipitation, genome-wide ChIP-seq, and knockdown expression/proliferation assays in mouse ESCs and human cancer lines (two concurrent papers)\",\n      \"pmids\": [\"27863225\", \"27863226\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic basis of the EPOP–Elongin BC interface not defined\", \"Functional role of USP7 recruitment not mechanistically dissected\", \"Link to Myc module correlative\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Crystallography of the EPOP BC-box bound to Elongin BC pinpointed Leu40 in the Elongin C hydrophobic pocket, giving the structural basis for the bridging interaction.\",\n      \"evidence\": \"X-ray crystallography of the EPOP BC-box peptide–Elongin BC complex\",\n      \"pmids\": [\"40153999\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure of full-length EPOP within PRC2 not determined\", \"Does not address the Elongin-BC-independent inhibitory function\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Reconstituted enzymatic assays demonstrated that EPOP stimulates PRC2 methyltransferase activity in a GCN-rich DNA-sequence-dependent manner, defining a positive, cooperative role with MTF2 and JARID2.\",\n      \"evidence\": \"In vitro HMT and dinucleosome binding assays on defined substrates plus EED-rescue in vivo system\",\n      \"pmids\": [\"41650228\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How sequence preference is read out mechanistically unclear\", \"Reconciliation with in-cell inhibitory role not fully resolved\", \"Single lab\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Separation-of-function mutants and dimerization assays established that EPOP restrains PRC2.1 by disrupting dimerization and lowering chromatin avidity, defining a distinct PRC2.1 subclass that prevents over-repression.\",\n      \"evidence\": \"Biochemical dimerization assays, PRC2-binding-deficient EPOP mutant, and genome-wide ChIP-seq in mouse epiblast-like cells (peer-reviewed publication of the 2024 preprint)\",\n      \"pmids\": [\"41519789\", \"39314288\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural detail of the dimerization-disrupting interaction not resolved\", \"How activating and inhibitory modes are partitioned across loci unknown\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"An Epop-knockout mouse linked EPOP's molecular restraint of PRC2 to organismal axial patterning, showing it prevents premature Hox activation in the presomitic mesoderm.\",\n      \"evidence\": \"Mouse knockout with skeletal phenotyping, tissue-specific RNA-seq, and Hox expression boundary analysis\",\n      \"pmids\": [\"40834979\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which EPOP biochemical activity (dimerization restraint vs Elongin BC bridging) drives the phenotype not dissected\", \"Human disease relevance untested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How EPOP's opposing activities — stimulating PRC2 methyltransferase activity yet restraining PRC2.1 chromatin over-targeting — are mechanistically partitioned at individual loci and contexts remains unresolved.\",\n      \"evidence\": null,\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model integrating activation and inhibition at the same target\", \"Role of USP7/H2B deubiquitination in the switch undefined\", \"No structure of EPOP within an intact PRC2.1 dimer\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [2, 3]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [4, 5, 6]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [6]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [0, 1, 2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [0, 1, 6]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [2, 3]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [8]}\n    ],\n    \"complexes\": [\"PRC2.1\"],\n    \"partners\": [\"EZH2\", \"SUZ12\", \"MTF2\", \"JARID2\", \"USP7\", \"ELOB\", \"ELOC\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":5,"faith_pct":100.0}}